Translational Research on Synergy of PD-1 Checkpoint Blockade and Oncolytic Measles Virotherapy

被引：0
|
作者：
Veinalde, Ruta [1 ,2 ]
Pidelaserra-Marti, Gemma [1 ,2 ]
Heidbuechel, Johannes P. W. [1 ,2 ]
Kang, Na [1 ,2 ]
Abate-Daga, Daniel [3 ]
Ball, Claudia R. [4 ,5 ]
Ungerechts, Guy [1 ,2 ]
Engeland, Christine E. [1 ,2 ]
机构：
[1] Natl Ctr Tumor Dis, Heidelberg, Germany
[2] German Canc Res Ctr, Heidelberg, Germany
[3] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
[4] Natl Ctr Tumor Dis, Dresden, Germany
[5] German Canc Res Ctr, Dresden, Germany
来源：
MOLECULAR THERAPY | 2019年 / 27卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
252
引用
收藏
页码：124 / 124
页数：1
相关论文
共 50 条
  • [31] Oncolytic measles vaccines encoding PD-1 and PD-L1 checkpoint blocking antibodies to increase tumor-specific T cell memory
    Veinalde, Ruta
    Pidelaserra-Marti, Gemma
    Moulin, Coline
    Jeworowski, Lara M.
    Kuether, Linda
    Buchholz, Christian J.
    Jaeger, Dirk
    Ungerechts, Guy
    Engeland, Christine E.
    MOLECULAR THERAPY-ONCOLYTICS, 2022, 24 : 43 - 58
  • [32] Local and abscopal effects in oncolytic virotherapy are boosted by immune checkpoint blockade, immunogenic chemotherapy, or IFNAR blockade
    Fend, Laetitia
    Yamazaki, Takahiro
    Preville, Xavier
    Quemeneur, Eric
    Kepp, Oliver
    Adam, Julien
    Marabelle, Aurelien
    Pitt, Jonathan
    Kroemer, Guido
    Zitvogel, Laurence
    CANCER RESEARCH, 2017, 77
  • [33] Challenges and potential of PD-1/PD-L1 checkpoint blockade immunotherapy for glioblastoma
    Xin Wang
    Gaochao Guo
    Hui Guan
    Yang Yu
    Jie Lu
    Jinming Yu
    Journal of Experimental & Clinical Cancer Research, 38
  • [34] The impact of oncolytic adenoviral therapy on the therapeutic efficacy of PD-1/PD-L1 blockade
    Najafi, Sajad
    Majidpoor, Jamal
    Mortezaee, Keywan
    BIOMEDICINE & PHARMACOTHERAPY, 2023, 161
  • [35] Phytochemicals in regulating PD-1/PD-L1 and immune checkpoint blockade therapy
    Zhang, Qi
    Yang, Chenying
    Gao, Xingsu
    Dong, Ju
    Zhong, Caiyun
    PHYTOTHERAPY RESEARCH, 2024, 38 (02) : 776 - 796
  • [36] Challenges and potential of PD-1/PD-L1 checkpoint blockade immunotherapy for glioblastoma
    Wang, Xin
    Guo, Gaochao
    Guan, Hui
    Yu, Yang
    Lu, Jie
    Yu, Jinming
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2019, 38 (1)
  • [37] PD-1–PD-L1 axis: efficient checkpoint blockade against cancer
    Alessia Errico
    Nature Reviews Clinical Oncology, 2015, 12 : 63 - 63
  • [38] PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
    Hartkopf, Andreas D.
    Taran, Florin-Andrei
    Wallwiener, Markus
    Walter, Christina B.
    Kraemer, Bernhard
    Grischke, Eva-Maria
    Brucker, Sara Y.
    BREAST CARE, 2016, 11 (06) : 385 - 390
  • [39] Predictive biomarkers for PD-1 and PD-L1 immune checkpoint blockade therapy
    Song, Yue
    Li, Zhaoming
    Xue, Weili
    Zhang, Mingzhi
    IMMUNOTHERAPY, 2019, 11 (06) : 515 - 529
  • [40] Combination of PD-1/PD-L1 checkpoint blockade and dendritic cell therapy
    Nesselhut, J.
    Marx, D.
    Lange, H.
    Chang, R. Y.
    Nesselhut, T.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2018, 48 : 95 - 95
12345